Drug intelligence / Profile preview

oxcarbazepine

Development stage
Approved
Lead developer
Novartis
Modality
Small Molecules
Administration
Oral
01

Overview

Oxcarbazepine is an anticonvulsant medication primarily used to treat epilepsy, specifically for the control of partial (focal) seizures in adults and children. It can be used alone or in combination with other antiepileptic drugs. Oxcarbazepine acts as a prodrug and is metabolized to its active form, licarbazepine (10-monohydroxy derivative). The drug works mainly by blocking voltage-sensitive sodium channels in neuronal membranes, stabilizing hyper-excited neural membranes, suppressing repetitive neuronal firing, and reducing synaptic impulse propagation. Additional effects may include enhanced potassium conductance and modulation of high-voltage activated calcium channels. Oxcarbazepine was developed as a safer alternative to carbamazepine with reduced hepatic risks due to differences in metabolism[1][4][5][8].

Brand names
TrileptalOxtellar XR
Other names
oxacarbazepine
02

Targets

VDCC (L-type voltage-dependent calcium channel (often specified further as subunits such as CaV1.2 in humans))KCNQ1 (Potassium voltage-gated channel subfamily KQT member 1)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on oxcarbazepine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxcarbazepine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call